Detailed information for compound 326759

Basic information

Technical information
  • TDR Targets ID: 326759
  • Name: 2-(furan-2-yl)-5-[4-[(2-methylsulfanylthiophe n-3-yl)methyl]piperazin-1-yl]-[1,2,4]triazolo [1,5-a][1,3,5]triazin-7-amine
  • MW: 428.534 | Formula: C18H20N8OS2
  • H donors: 1 H acceptors: 4 LogP: 2.57 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1sccc1CN1CCN(CC1)c1nc(N)n2c(n1)nc(n2)c1ccco1
  • InChi: 1S/C18H20N8OS2/c1-28-15-12(4-10-29-15)11-24-5-7-25(8-6-24)17-21-16(19)26-18(22-17)20-14(23-26)13-3-2-9-27-13/h2-4,9-10H,5-8,11H2,1H3,(H2,19,20,21,22,23)
  • InChiKey: SQYCMFDPNZUWLY-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(2-furyl)-5-[4-[(2-methylsulfanyl-3-thienyl)methyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine
  • 2-(2-furyl)-5-[4-[[2-(methylthio)-3-thienyl]methyl]-1-piperazinyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine
  • [2-(2-furyl)-5-[4-[[2-(methylthio)-3-thienyl]methyl]piperazino]-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-yl]amine
  • 2-furan-2-yl-5-[4-[(2-methylsulfanylthiophen-3-yl)methyl]piperazin-1-yl]-[1,2,4]triazolo[5,1-f][1,3,5]triazin-7-amine
  • 2-(2-furyl)-5-[4-[(2-methylsulfanyl-3-thienyl)methyl]piperazin-1-yl]-[1,2,4]triazolo[5,1-f][1,3,5]triazin-7-amine
  • 2-(2-furyl)-5-[4-[[2-(methylthio)-3-thienyl]methyl]-1-piperazinyl]-[1,2,4]triazolo[5,1-f][1,3,5]triazin-7-amine
  • [2-(2-furyl)-5-[4-[[2-(methylthio)-3-thienyl]methyl]piperazin-1-yl]-[1,2,4]triazolo[5,1-f][1,3,5]triazin-7-yl]amine

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Adenosine A2a receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Schistosoma mansoni biogenic amine (5HT) receptor Adenosine A2a receptor   410 aa 399 aa 28.1 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 337 aa 23.1 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 356 aa 23.9 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Adenosine A2a receptor   410 aa 366 aa 25.4 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Adenosine A2a receptor   410 aa 346 aa 28.3 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A2a receptor   410 aa 352 aa 23.6 %
Echinococcus multilocularis allatostatin A receptor Adenosine A2a receptor   410 aa 372 aa 22.8 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Adenosine A2a receptor   410 aa 340 aa 27.9 %
Echinococcus granulosus allatostatin A receptor Adenosine A2a receptor   410 aa 368 aa 22.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi thymidylate synthase 0.0538 0.7011 1
Schistosoma mansoni growth factor receptor-bound protein 0.0037 0.0183 0.0261
Echinococcus granulosus tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Chlamydia trachomatis dihydrofolate reductase 0.0219 0.267 0.5
Loa Loa (eye worm) SRC-1 0.0042 0.0254 0.0354
Echinococcus multilocularis tyrosine protein kinase Abl 0.0042 0.0254 0.0354
Brugia malayi Variant SH3 domain containing protein 0.0037 0.0183 0.0252
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.0757 1 0.5
Echinococcus multilocularis tyrosine protein kinase Fgr 0.0042 0.0254 0.0354
Schistosoma mansoni dihydrofolate reductase 0.0219 0.267 0.3808
Echinococcus multilocularis tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase 0.0042 0.0254 0.0354
Schistosoma mansoni tyrosine kinase 0.0042 0.0254 0.0362
Loa Loa (eye worm) variant SH3 domain-containing protein 0.0037 0.0183 0.0252
Echinococcus granulosus proto oncogene tyrosine protein kinase LCK 0.0042 0.0254 0.0354
Schistosoma mansoni tyrosine kinase 0.0024 0.0006 0.0009
Brugia malayi Dihydrofolate reductase 0.0219 0.267 0.3803
Echinococcus granulosus tyrosine protein kinase Src42A 0.0042 0.0254 0.0354
Echinococcus granulosus c src tyrosine kinase 0.0042 0.0254 0.0354
Schistosoma mansoni tyrosine kinase 0.0024 0.0006 0.0009
Schistosoma mansoni growth factor receptor-bound protein 0.0037 0.0183 0.0261
Mycobacterium leprae PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) 0.0538 0.7011 1
Echinococcus multilocularis growth factor receptor bound protein 2 0.0037 0.0183 0.0252
Schistosoma mansoni tyrosine kinase 0.0042 0.0254 0.0362
Brugia malayi dihydrofolate reductase family protein 0.0219 0.267 0.3803
Mycobacterium ulcerans thymidylate synthase 0.0538 0.7011 1
Echinococcus granulosus tyrosine protein kinase Src64B 0.0042 0.0254 0.0354
Echinococcus multilocularis tyrosine protein kinase lyn tyrosine protein kinase blk 0.0042 0.0254 0.0354
Echinococcus multilocularis c src tyrosine kinase 0.0042 0.0254 0.0354
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.0757 1 0.5
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.0757 1 1
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Schistosoma mansoni proto-oncogene tyrosine-protein kinase src 0.0042 0.0254 0.0362
Schistosoma mansoni bifunctional dihydrofolate reductase-thymidylate synthase 0.0538 0.7011 1
Schistosoma mansoni adapter molecule crk 0.0037 0.0183 0.0261
Echinococcus multilocularis dihydrofolate reductase 0.0219 0.267 0.3803
Mycobacterium tuberculosis Probable thymidylate synthase ThyA (ts) (TSASE) 0.0538 0.7011 1
Echinococcus granulosus thymidylate synthase 0.0538 0.7011 1
Brugia malayi SRC-1 0.0042 0.0254 0.0354
Loa Loa (eye worm) thymidylate synthase 0.0538 0.7011 1
Echinococcus granulosus tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Echinococcus granulosus dihydrofolate reductase 0.0219 0.267 0.3803
Schistosoma mansoni tyrosine kinase 0.0042 0.0254 0.0362
Echinococcus granulosus NCK adaptor protein 0.0037 0.0183 0.0252
Entamoeba histolytica SH2-protein kinase domain containing protein 0.0024 0.0006 0.5
Schistosoma mansoni nck2/grb4 0.0037 0.0183 0.0261
Echinococcus multilocularis tyrosine protein kinase Src42A 0.0042 0.0254 0.0354
Loa Loa (eye worm) hypothetical protein 0.0037 0.0183 0.0252
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Echinococcus granulosus growth factor receptor bound protein 2 0.0037 0.0183 0.0252
Brugia malayi Tyrosine-protein kinase abl-1 0.0042 0.0254 0.0354
Loa Loa (eye worm) dihydrofolate reductase 0.0219 0.267 0.3803
Schistosoma mansoni proto-oncogene tyrosine-protein kinase abl1 0.0037 0.0183 0.0261
Echinococcus granulosus 3'partial|tyrosine protein kinase Fgr 0.0042 0.0254 0.0354
Onchocerca volvulus 0.0538 0.7011 1
Echinococcus multilocularis NCK adaptor protein 0.0037 0.0183 0.0252
Brugia malayi Sex muscle abnormal protein 5 0.0037 0.0183 0.0252
Schistosoma mansoni tyrosine kinase 0.0042 0.0254 0.0362
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Echinococcus multilocularis thymidylate synthase 0.0538 0.7011 1
Echinococcus granulosus tyrosine protein kinase Fyn 0.0042 0.0254 0.0354
Echinococcus granulosus tyrosine protein kinase Btk29A 0.0042 0.0254 0.0354
Brugia malayi Variant SH3 domain containing protein 0.0037 0.0183 0.0252
Echinococcus granulosus tyrosine protein kinase Lyn 0.0042 0.0254 0.0354
Mycobacterium tuberculosis Hypothetical protein 0.0256 0.3168 0.1148
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.0757 1 0.5
Echinococcus multilocularis tyrosine protein kinase Src64B 0.0042 0.0254 0.0354
Brugia malayi hypothetical protein 0.0256 0.3168 0.4514
Echinococcus multilocularis tyrosine protein kinase Btk29A 0.0042 0.0254 0.0354
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.0757 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0256 0.3168 0.5
Echinococcus multilocularis proto oncogene tyrosine protein kinase LCK 0.0042 0.0254 0.0354
Loa Loa (eye worm) sex muscle abnormal protein 5 0.0037 0.0183 0.0252

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) Compound was tested in mouse catalepsy study (po); inactive at 10 mg/kg ChEMBL. 15294001
Activity (functional) 0 Compound was tested in mouse catalepsy study (po); inactive at 10 mg/kg ChEMBL. 15294001
ED50 (functional) 0 mg kg-1 Effective peroral dose of the compound in rat catalepsy study ChEMBL. 15294001
Ki (binding) nM Inhibition of [3H]-DPCPX binding to rat cerebral cortex adenosine A1 receptor ChEMBL. 15294001
Ki (binding) 0 nM Inhibition of [3H]-DPCPX binding to rat cerebral cortex adenosine A1 receptor ChEMBL. 15294001
Ki (binding) = 35 nM Inhibition of [3H]-ZM-241,385 binidng to rat brain adenosine A2a receptor ChEMBL. 15294001
Ki (binding) = 35 nM Inhibition of [3H]-ZM-241,385 binidng to rat brain adenosine A2a receptor ChEMBL. 15294001
MED (functional) 0 mg kg-1 Minimum effective dose (po) for 6-hydroxydopamine rotation in male Sprague-Dawley rats ChEMBL. 15294001

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.